Funding Rounds
Memo Therapeutics

Memo Therapeutics Series A (2015, $2M)

Memo Therapeutics

Antibody discovery and human immune repertoire analysis platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $2.30M

Investors